Trials / Conditions / Non-Myeloid Malignancies

Non-Myeloid Malignancies

11 registered clinical trials studyying Non-Myeloid Malignancies — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies NCT06854276	Shenyang Sunshine Pharmaceutical Co., LTD.	Phase 2
Completed	A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating A NCT01145638	Pharmacosmos A/S	Phase 3
Completed	Darbepoetin Alfa With or Without Intravenous (IV) Iron NCT00401544	Amgen	Phase 2
Completed	Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non NCT00239239	Amgen	Phase 2
Completed	A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Mult NCT00118638	Amgen	Phase 3
Completed	Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy NCT00110955	Amgen	Phase 3
Completed	Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy NCT00111137	Amgen	Phase 3
Terminated	Darbepoetin Alfa and Anemia of Cancer NCT00989092	Amgen	Phase 2
Completed	Chemotherapy Related Anemia NCT00035607	Amgen	Phase 2
Completed	Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Rece NCT00540696	Amgen	Phase 2
Completed	Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy NCT00111462	Amgen	Phase 2